Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2018

Publisher : XYZResearch Publication Date : Jun 12, 2018

Number of Pages : 103 Subcategory : Pharmaceuticals
Single User $ 2800
Global User $ 5500

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    GE Healthcare
    Philips Healthcare
    Siemens Healthcare
    Toshiba
    Hitachi
    Carestream
    Esaote
    Shimadzu
    TriFoil Imaging
    Biosensors International Group, Ltd

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes

    By Application, the market can be split into
    Diagnostic Applications: SPECT, PET.
    Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.

    By Regions, this report covers (we can add the regions/countries as you want)
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    If you have any special requirements, please let us know and we will offer you the report as you want.

  • Table of Content

    Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2018

    Table of Contents

    Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2017
    1 Industry Overview of Nuclear Medicine & Radio Pharmaceuticals
    1.1 Definition and Specifications of Nuclear Medicine & Radio Pharmaceuticals
    1.1.1 Definition of Nuclear Medicine & Radio Pharmaceuticals
    1.1.2 Specifications of Nuclear Medicine & Radio Pharmaceuticals
    1.2 Classification of Nuclear Medicine & Radio Pharmaceuticals
    1.2.1 Global Nuclear Medicine & Radio Pharmaceuticals Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
    1.2.2 Global Nuclear Medicine & Radio Pharmaceuticals Production Market Share (%) by Types in 2017
    1.2.3 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    1.2.4 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    1.3 Applications of Nuclear Medicine & Radio Pharmaceuticals
    1.3.1 Global Nuclear Medicine & Radio Pharmaceuticals Consumption (K Units) Comparison by Applications (2012-2023)
    1.3.2 Diagnostic Applications: SPECT, PET.
    1.3.3 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications.
    1.4 Global Nuclear Medicine & Radio PharmaceuticalsMarket by Regions (2012-2023)
    1.4.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Size and Growth Rate (%) Comparison by Regions (2012-2023)
    1.4.2 North AmericaNuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2023)
    1.4.3 EuropeNuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2023)
    1.4.4 ChinaNuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2023)
    1.4.5 JapanNuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2023)
    1.4.6 Southeast AsiaNuclear Medicine & Radio Pharmaceuticals Status and Prospect (2012-2023)
    1.5 Global Nuclear Medicine & Radio Pharmaceuticals Market Size (2012-2023)
    1.5.1 Global Nuclear Medicine & Radio Pharmaceuticals Revenue (Million USD) Status and Outlook (2012-2023)
    1.5.2 Global Nuclear Medicine & Radio Pharmaceuticals Capacity, Production (K Units) Status and Outlook (2012-2023)

    2 Industrial Chain Analysis
    2.1 Industry Chain Structure of Nuclear Medicine & Radio Pharmaceuticals
    2.2 Raw Material Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.2.1 Raw Material A Market Analysis
    2.2.2 Raw Material B Market Analysis
    2.2.3 Raw Material C Market Analysis
    2.3 Labor Cost Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.4 Other Costs Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.5 Manufacturing Cost Structure Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.6 Manufacturing Process Analysis of Nuclear Medicine & Radio Pharmaceuticals
    2.7 Raw Materials Sources of Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2017
    2.8 Downstream Buyers of Nuclear Medicine & Radio Pharmaceuticals

    3 Global Nuclear Medicine & Radio Pharmaceuticals Manufacturers Profiles/Analysis
    3.1 GE Healthcare
    3.1.1 Company Basic Information, Manufacturing Base and Competitors
    3.1.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.1.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.1.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.1.3 GE Healthcare 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.1.4 GE Healthcare 2017 Business Region Distribution Analysis
    3.1.5 GE Healthcare Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.2 Philips Healthcare
    3.2.1 Company Basic Information, Manufacturing Base and Competitors
    3.2.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.2.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.2.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.2.3 Philips Healthcare 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.2.4 Philips Healthcare 2017 Business Region Distribution Analysis
    3.2.5 Philips Healthcare Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.3 Siemens Healthcare
    3.3.1 Company Basic Information, Manufacturing Base and Competitors
    3.3.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.3.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.3.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.3.3 Siemens Healthcare 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.3.4 Siemens Healthcare 2017 Business Region Distribution Analysis
    3.3.5 Siemens Healthcare Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.4 Toshiba
    3.4.1 Company Basic Information, Manufacturing Base and Competitors
    3.4.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.4.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.4.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.4.3 Toshiba 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.4.4 Toshiba 2017 Business Region Distribution Analysis
    3.4.5 Toshiba Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.5 Hitachi
    3.5.1 Company Basic Information, Manufacturing Base and Competitors
    3.5.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.5.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.5.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.5.3 Hitachi 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.5.4 Hitachi 2017 Business Region Distribution Analysis
    3.5.5 Hitachi Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.6 Carestream
    3.6.1 Company Basic Information, Manufacturing Base and Competitors
    3.6.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.6.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.6.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.6.3 Carestream Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.6.4 Carestream 2017 Business Region Distribution Analysis
    3.6.5 Carestream Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.7 Esaote
    3.7.1 Company Basic Information, Manufacturing Base and Competitors
    3.7.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.7.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.7.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.7.3 Esaote 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.7.4 Esaote 2017 Business Region Distribution Analysis
    3.7.5 Esaote Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.8 Shimadzu
    3.8.1 Company Basic Information, Manufacturing Base and Competitors
    3.8.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.8.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.8.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.8.3 Shimadzu 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.8.4 Shimadzu 2017 Business Region Distribution Analysis
    3.8.5 Shimadzu Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.9 TriFoil Imaging
    3.9.1 Company Basic Information, Manufacturing Base and Competitors
    3.9.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.9.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.9.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.9.3 TriFoil Imaging 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.9.4 TriFoil Imaging 2017 Business Region Distribution Analysis
    3.9.5 TriFoil Imaging Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share
    3.10 Biosensors International Group, Ltd
    3.10.1 Company Basic Information, Manufacturing Base and Competitors
    3.10.2 Nuclear Medicine & Radio Pharmaceuticals Product Category, Application and Specification
    3.10.2.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals
    3.10.2.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes
    3.10.3 Biosensors International Group, Ltd 2017 Nuclear Medicine & Radio Pharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.10.4 Biosensors International Group, Ltd 2017 Business Region Distribution Analysis
    3.10.5 Biosensors International Group, Ltd Nuclear Medicine & Radio Pharmaceuticals Volume in Different Applications and Its Application Share

    4 Technical Data and Manufacturing Plants Analysis of Nuclear Medicine & Radio Pharmaceuticals
    4.1 Capacity and Commercial Production Date of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2017
    4.2 Manufacturing Plants Distribution of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2017
    4.4 R&D Status and Technology Source of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2017
    4.4 Raw Materials Sources Analysis of Global Nuclear Medicine & Radio Pharmaceuticals Major Manufacturers in 2017

    5 Global Nuclear Medicine & Radio Pharmaceuticals Overall Market Overview
    5.1 2012-2017 Overall Market Analysis
    5.2 Capacity Analysis
    5.2.1 2012-2017 Global Nuclear Medicine & Radio Pharmaceuticals Capacity and Growth Rate Analysis
    5.2.2 2017 Nuclear Medicine & Radio Pharmaceuticals Capacity Analysis (Company Segment)
    5.3 Sales Analysis
    5.3.1 2012-2017 Global Nuclear Medicine & Radio Pharmaceuticals Sales and Growth Rate Analysis
    5.3.2 2017 Nuclear Medicine & Radio Pharmaceuticals Sales Analysis (Company Segment)
    5.4 Sales Price Analysis
    5.4.1 2012-2017 Global Nuclear Medicine & Radio Pharmaceuticals Sales Price
    5.4.2 2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis (Company Segment)

    6 Nuclear Medicine & Radio Pharmaceuticals Regional Market Analysis
    6.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.1.1 North America Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.1.2 North America 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.1.3 North America 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.1.4 North America 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    6.2 Europe Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.2.1 Europe Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.2.2 Europe 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.2.3 Europe 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.2.4 Europe 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    6.3 China Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.3.1 China Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.3.2 China 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.3.3 China 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.3.4 China 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    6.4 Japan Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.4.1 Japan Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.4.2 Japan 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.4.3 Japan 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.4.4 Japan 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    6.5 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.5.1 Southeast Asia Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.5.2 Southeast Asia 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.5.3 Southeast Asia 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.5.4 Southeast Asia 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis
    6.6 India Nuclear Medicine & Radio Pharmaceuticals Market Analysis
    6.6.1 India Nuclear Medicine & Radio Pharmaceuticals Market Overview
    6.6.2 India 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.6.3 India 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales Price Analysis
    6.6.4 India 2017 Nuclear Medicine & Radio Pharmaceuticals Market Share Analysis

    7 Global 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Type)
    7.1 Global 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Sales by Type
    7.2 Different Types of Nuclear Medicine & Radio Pharmaceuticals Product Interview Price Analysis
    7.3 Different Types of Nuclear Medicine & Radio Pharmaceuticals Product Driving Factors Analysis
    7.3.1 Diagnostic Medicine: SPECT Radiopharmaceuticals, PET Radiopharmaceuticals of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis
    7.3.2 Therapeutic Medicine: Beta Emitters, Alpha Emitters, Brachytherapy Isotopes of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis

    8 Global 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Segment Market Analysis (by Application)
    8.1 Global 2012-2017 Nuclear Medicine & Radio Pharmaceuticals Consumption by Application
    8.2 Different Application of Nuclear Medicine & Radio Pharmaceuticals Product Interview Price Analysis
    8.3 Different Application of Nuclear Medicine & Radio Pharmaceuticals Product Driving Factors Analysis
    8.3.1 Diagnostic Applications: SPECT, PET. of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis
    8.3.2 Therapeutic Applications: Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumors, Other Therapeutic Applications. of Nuclear Medicine & Radio Pharmaceuticals Growth Driving Factor Analysis

    9 Development Trend of Analysis of Nuclear Medicine & Radio Pharmaceuticals Market
    9.1 Global Nuclear Medicine & Radio Pharmaceuticals Market Trend Analysis
    9.1.1 Global 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Market Size (Volume and Value) Forecast
    9.1.2 Global 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Sales Price Forecast
    9.2 Nuclear Medicine & Radio Pharmaceuticals Regional Market Trend
    9.2.1 North America 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.2.2 Europe 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.2.3 China 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.2.4 Japan 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.2.5 Southeast Asia 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.2.6 India 2018-2023 Nuclear Medicine & Radio Pharmaceuticals Consumption Forecast
    9.3 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Product Type)
    9.4 Nuclear Medicine & Radio Pharmaceuticals Market Trend (Application)

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Nuclear Medicine & Radio Pharmaceuticals Marketing Type Analysis
    11.1 Nuclear Medicine & Radio Pharmaceuticals Regional Marketing Type Analysis
    11.2 Nuclear Medicine & Radio Pharmaceuticals International Trade Type Analysis
    11.3 Traders or Distributors with Contact Information of Nuclear Medicine & Radio Pharmaceuticals by Region
    11.4 Nuclear Medicine & Radio Pharmaceuticals Supply Chain Analysis

    12 Consumers Analysis of Nuclear Medicine & Radio Pharmaceuticals
    12.1 Consumer 1 Analysis
    12.2 Consumer 2 Analysis
    12.3 Consumer 3 Analysis
    12.4 Consumer 4 Analysis

    13 Conclusion of the Global Nuclear Medicine & Radio Pharmaceuticals Market Professional Survey Report 2018

    14 Methodology and Data Source
    14.1 Methodology/Research Approach
    14.1.1 Research Programs/Design
    14.1.2 Market Size Estimation
    14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
    14.2.1 Secondary Sources
    14.2.2 Primary Sources
    14.3 Disclaimer
    14.4 Author List

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

Related Products
$2500 - $5000 - $5000
Publisher : 99Strategy Publication Date : Sep 16, 2018

Number of Pages : 97 Subcategory : Pharmaceuticals